查詢結果分析
相關文獻
- 起皰性化學藥物外滲結果指標之建立
- 降低化學治療外滲的發生率
- Bullous Eruptions Caused by Extravasation of Mannitol:A Case Report
- 抗癌藥物外滲的處理
- 靜脈外滲性傷害之治療
- Nontraumatic Rupture of Urinary Tract
- Spontaneous Rupture of the Ureter Secondary to Urolithiasis and Extravasation of Calyceal Fornix due to Acute Urinary Bladder Distension: Four Cases Report
- 預防及處置新生兒非化療藥外滲
- 降低門診化學治療室化學治療藥物外滲之改善專案
- 共匪對外滲透與匪俄鬥爭
頁籤選單縮合
題 名 | 起皰性化學藥物外滲結果指標之建立=The Establishment of an Outcome Indicator of Vesicant Extravasation |
---|---|
作 者 | 張碧華; 王富瑩; 邱春幸; 楊克平; | 書刊名 | 榮總護理 |
卷 期 | 16:1 1999.03[民88.03] |
頁 次 | 頁69-79 |
分類號 | 419.77 |
關鍵詞 | 起皰性化學藥物; 外滲; 結果指標; Vesicant; Extravasation; Outcome indicator; |
語 文 | 中文(Chinese) |
中文摘要 | 本專案的目的是建立起皰性化學藥物外滲之病患結果指標。起皰性化學藥物外滲 是化學治療的合併症之一,也是唯一可以藉由護理措施預防的副作用。本專案之 進行,運用FOCUS P-D-C-A問題解決法及病患結果指標評量過程,確立起皰性化 學藥物外滲是一個高等量、高危險及高成本的護理問題,且預防病患發生藥物外 滲,是最好的病患結果。自民國85年9月至民國87年7月監測起皰性化學藥物 外滲發生率,且於民國86年3月至I0月訂立指標及設定閾值(< 3%)。統計結果 顯示:民國85年9月及10月各有一例,外滲率為2﹪,85年II月至87年6月 間之外滲率為0,87年7月則有一例疑似外滲之個案,外滲率為I.6﹪,均在本 專案設定之閾值內。由此結果可知,本專案之施行,確實能達到良好之病患結果。 本專案結果指標之建立,可由病患結果評量的過程持續監測護理措施之成效 ,作為日後改善方針,進而提昇護理品質,以達到起皰性化學藥物外滲發生率為 0之永久目標。 |
英文摘要 | The purpose of this project was to establish a patient outcome indicator of vesicant exravasation. The vesicant extravasation is one of the many complications in chemotherapy, and which can be prevented by appropriate nursing interventions. The FOCUS P-D-C-A cycle method and the process of patient outcome measurement were used to identify the vesicant extravasation of which there was a high volume, high risk, and high cost problem. It was recognized that one of the best patient outcomes from chemotherapy should be that no patient has any extravasation wound. In the outcome measurement, the vesicant extravasation occurrence rate was monitored from September 1996 to July 1998; the indicator and threshold(< 3%) were also established from March to October in 1996. The occurrence rate was 2% in both September and October of 1996, zero from November of 1996 to June of 1998, and 1.6% in July 1998. All of the occurrence rates were within the established threshold. The results indicated that the patients with chemotherapy achieved a very optimal outcome in preventing vesicant extravasation. As a result, the outcome indicator of vesicant extravasation was successfully established. It should be noticed however that continued monitoring of patient outcome through this developed measurement process will improve the quality of nursing as well as achieve the goal of a zero rate on the vesicant extravasation. |
本系統中英文摘要資訊取自各篇刊載內容。